40 related articles for article (PubMed ID: 23257445)
1. [Expression of MCL-1 and BAK proteins in nutritional anemia and its clinical significance].
Guo YJ; Wang Y; Lin FR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1419-22. PubMed ID: 23257445
[TBL] [Abstract][Full Text] [Related]
2. Clitocine induces apoptosis and enhances the lethality of ABT-737 in human colon cancer cells by disrupting the interaction of Mcl-1 and Bak.
Sun JG; Xiang J; Zeng XL; Li X; Wu P; Fung KP; Liu FY
Cancer Lett; 2014 Dec; 355(2):253-63. PubMed ID: 25304383
[TBL] [Abstract][Full Text] [Related]
3. Anti-apoptotic capacity of Mcl-1Δ127.
Wang Y; Su W; Mai Z; Yu S; Wang X; Chen T
Biochem Biophys Res Commun; 2020 Jun; 526(4):1042-1048. PubMed ID: 32331834
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of the pro-apoptotic factor Bak is controlled by antagonist factor Mcl-1 availability.
Minet E; Cosse JP; Demazy C; Raes M; Michiels C
Apoptosis; 2006 Jun; 11(6):1039-47. PubMed ID: 16547591
[TBL] [Abstract][Full Text] [Related]
5. Imperatorin induces Mcl-1 degradation to cooperatively trigger Bax translocation and Bak activation to suppress drug-resistant human hepatoma.
Li X; Zeng X; Sun J; Li H; Wu P; Fung KP; Liu F
Cancer Lett; 2014 Jun; 348(1-2):146-55. PubMed ID: 24680709
[TBL] [Abstract][Full Text] [Related]
6. NDRG2 contributes to cisplatin sensitivity through modulation of BAK-to-Mcl-1 ratio.
Park S; Oh SS; Lee KW; Lee YK; Kim NY; Kim JH; Yoo J; Kim KD
Cell Death Dis; 2018 Jan; 9(2):30. PubMed ID: 29348517
[TBL] [Abstract][Full Text] [Related]
7. Clitocine targets Mcl-1 to induce drug-resistant human cancer cell apoptosis in vitro and tumor growth inhibition in vivo.
Sun JG; Li H; Li X; Zeng X; Wu P; Fung KP; Liu FY
Apoptosis; 2014 May; 19(5):871-82. PubMed ID: 24563182
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide rewires mantle cell lymphoma response to bortezomib.
Zhao LL; Liu YF; Peng LJ; Fei AM; Cui W; Miao SC; Hermine O; Gressin R; Khochbin S; Chen SJ; Wang J; Mi JQ
Cancer Med; 2015 Nov; 4(11):1754-66. PubMed ID: 26310857
[TBL] [Abstract][Full Text] [Related]
9. Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1.
Desrat S; Pujals A; Colas C; Dardenne J; Gény C; Favre L; Dumontet V; Iorga BI; Litaudon M; Raphaël M; Wiels J; Roussi F
Bioorg Med Chem Lett; 2014 Nov; 24(21):5086-8. PubMed ID: 25266781
[TBL] [Abstract][Full Text] [Related]
10. Bak deficiency inhibits liver carcinogenesis: a causal link between apoptosis and carcinogenesis.
Hikita H; Kodama T; Shimizu S; Li W; Shigekawa M; Tanaka S; Hosui A; Miyagi T; Tatsumi T; Kanto T; Hiramatsu N; Morii E; Hayashi N; Takehara T
J Hepatol; 2012 Jul; 57(1):92-100. PubMed ID: 22414765
[TBL] [Abstract][Full Text] [Related]
11. Structural Re-engineering of the α-Helix Mimetic JY-1-106 into Small Molecules: Disruption of the Mcl-1-Bak-BH3 Protein-Protein Interaction with 2,6-Di-Substituted Nicotinates.
Drennen B; Scheenstra JA; Yap JL; Chen L; Lanning ME; Roth BM; Wilder PT; Fletcher S
ChemMedChem; 2016 Apr; 11(8):827-33. PubMed ID: 26844930
[TBL] [Abstract][Full Text] [Related]
12. M. leprae inhibits apoptosis in THP-1 cells by downregulation of Bad and Bak and upregulation of Mcl-1 gene expression.
Hasan Z; Ashraf M; Tayyebi A; Hussain R
BMC Microbiol; 2006 Sep; 6():78. PubMed ID: 16978419
[TBL] [Abstract][Full Text] [Related]
13. Expression of Bak and Bak/Mcl-1 ratio can predict photodynamic therapy outcome for oral verrucous hyperplasia and leukoplakia.
Yu CH; Chen HM; Lin HP; Chiang CP
J Oral Pathol Med; 2013 Mar; 42(3):257-62. PubMed ID: 22974427
[TBL] [Abstract][Full Text] [Related]
14. Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer.
Wesarg E; Hoffarth S; Wiewrodt R; Kröll M; Biesterfeld S; Huber C; Schuler M
Int J Cancer; 2007 Dec; 121(11):2387-94. PubMed ID: 17688235
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical assessment of apoptosis-associated proteins: p53, Bcl-xL, Bax and Bak in gastric cancer cells in correlation with clinical and pathomorphological factors.
Gryko M; Pryczynicz A; Guzińska-Ustymowicz K; Kamocki Z; Zaręba K; Kemona A; Kędra B
Adv Med Sci; 2012 Jun; 57(1):77-83. PubMed ID: 22440942
[TBL] [Abstract][Full Text] [Related]
16. A novel BH3 mimetic S1 potently induces Bax/Bak-dependent apoptosis by targeting both Bcl-2 and Mcl-1.
Zhang Z; Song T; Zhang T; Gao J; Wu G; An L; Du G
Int J Cancer; 2011 Apr; 128(7):1724-35. PubMed ID: 20503275
[TBL] [Abstract][Full Text] [Related]
17. Pan-BH3 mimetic S1 exhibits broad-spectrum antitumour effects by cooperation between Bax and Bak.
Song T; Xue Z; Zhang Z; Shen X; Li X
Basic Clin Pharmacol Toxicol; 2013 Sep; 113(3):145-51. PubMed ID: 23557083
[TBL] [Abstract][Full Text] [Related]
18. Enhanced basal apoptosis in cultured term human cytotrophoblasts is associated with a higher expression and physical interaction of p53 and Bak.
Hu C; Smith SD; Pang L; Sadovsky Y; Nelson DM
Placenta; 2006; 27(9-10):978-83. PubMed ID: 16376985
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
20. Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers.
Modugno M; Banfi P; Gasparri F; Borzilleri R; Carter P; Cornelius L; Gottardis M; Lee V; Mapelli C; Naglich JG; Tebben A; Vite G; Pastori W; Albanese C; Corti E; Ballinari D; Galvani A
Exp Cell Res; 2015 Mar; 332(2):267-77. PubMed ID: 25486070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
